Search research articles
Contact Us
Filters
Showing results (31-40 of 122) with videos related to
Page
of 13
Sort By:
Heart Rhythm
|
August 28, 2017
Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology
Pieter Martens, Petra Nijst, Frederik H Verbrugge, et al.
International Journal of Cardiology
|
May 27, 2017
Renal response to intravascular volume expansion in euvolemic heart failure patients with reduced ejection fraction: Mechanistic insights and clinical implications
Petra Nijst, Frederik H Verbrugge, Pieter Martens, et al.
Circulation. Heart Failure
|
July 20, 2014
Urinary composition during decongestive treatment in heart failure with reduced ejection fraction
Frederik H Verbrugge, Petra Nijst, Matthias Dupont, et al.
Journal of Cardiovascular Translational Research
|
February 27, 2020
Cardiovascular Volume Reserve in Patients with Heart Failure and Reduced Ejection Fraction
Petra Nijst, Pieter Martens, Frederik H Verbrugge, et al.
Acta Cardiologica
|
November 8, 2019
Determinants of maximal dose titration of sacubitril/valsartan in clinical practice
Pieter Martens, Lina Verluyten, Heleen Van de Broek, et al.
ESC Heart Failure
|
September 29, 2019
Rationale and design of the IRON-CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy
Pieter Martens, Matthias Dupont, Jeroen Dauw, et al.
European Journal of Heart Failure
|
January 5, 2013
Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment
Matthias Dupont, Wilfried Mullens, Michael Finucan, et al.
Clinical Cardiology
|
September 10, 2019
Implications of renin-angiotensin-system blocker discontinuation in acute decompensated heart failure with systolic dysfunction
Douglas Darden, Mark H Drazner, Wilfried Mullens, et al.
The American Journal of Cardiology
|
November 30, 2013
Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions
Frederik H Verbrugge, Jürgen Duchenne, Philippe B Bertrand, et al.
Microcirculation (New York, N.Y. : 1994)
|
December 7, 2017
Endovascular shedding markers in patients with heart failure with reduced ejection fraction: Results from a single-center exploratory study
Petra Nijst, Jirka Cops, Pieter Martens, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 122) with videos related to
Sort By:
Page
of 13
Heart Rhythm
|
August 28, 2017
Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology
Pieter Martens, Petra Nijst, Frederik H Verbrugge, et al.
International Journal of Cardiology
|
May 27, 2017
Renal response to intravascular volume expansion in euvolemic heart failure patients with reduced ejection fraction: Mechanistic insights and clinical implications
Petra Nijst, Frederik H Verbrugge, Pieter Martens, et al.
Circulation. Heart Failure
|
July 20, 2014
Urinary composition during decongestive treatment in heart failure with reduced ejection fraction
Frederik H Verbrugge, Petra Nijst, Matthias Dupont, et al.
Journal of Cardiovascular Translational Research
|
February 27, 2020
Cardiovascular Volume Reserve in Patients with Heart Failure and Reduced Ejection Fraction
Petra Nijst, Pieter Martens, Frederik H Verbrugge, et al.
Acta Cardiologica
|
November 8, 2019
Determinants of maximal dose titration of sacubitril/valsartan in clinical practice
Pieter Martens, Lina Verluyten, Heleen Van de Broek, et al.
ESC Heart Failure
|
September 29, 2019
Rationale and design of the IRON-CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy
Pieter Martens, Matthias Dupont, Jeroen Dauw, et al.
European Journal of Heart Failure
|
January 5, 2013
Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment
Matthias Dupont, Wilfried Mullens, Michael Finucan, et al.
Clinical Cardiology
|
September 10, 2019
Implications of renin-angiotensin-system blocker discontinuation in acute decompensated heart failure with systolic dysfunction
Douglas Darden, Mark H Drazner, Wilfried Mullens, et al.
The American Journal of Cardiology
|
November 30, 2013
Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions
Frederik H Verbrugge, Jürgen Duchenne, Philippe B Bertrand, et al.
Microcirculation (New York, N.Y. : 1994)
|
December 7, 2017
Endovascular shedding markers in patients with heart failure with reduced ejection fraction: Results from a single-center exploratory study
Petra Nijst, Jirka Cops, Pieter Martens, et al.
Page
of 13